Gocovri

Product manufactured by Adamas Pharma, Llc

Application Nr Approved Date Route Status External Links
NDA208944 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Gocovri ® Is Indicated For The Treatment Of Dyskinesia In Patients With Parkinson’s Disease Receiving Levodopa-Based Therapy, With Or Without Concomitant Dopaminergic Medications. Gocovri ® Is Indicated For The Treatment Of Dyskinesia In Patients With Parkinson’s Disease Receiving Levodopa-Based Therapy, With Or Without Concomitant Dopaminergic Medications ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Amantadine AMANTADINE ZINC968256

Comments